ArticleEuropean journal of nuclear medicine and molecular imaging2026
Exceptional brain PET images from the NeuroEXPLORER: scans with targeted radiopharmaceuticals and comparison to HRRT.
Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Brain PET in the era of anti-amyloid-β antibody therapy for Alzheimer disease.Japanese journal of radiology · 2026Review
- Eagle eyes on the human brain and beyond: PET at ultra-high spatial resolution.European journal of nuclear medicine and molecular imaging · 2026Article
- PICASSO: a universal brain phantom for positron emission tomography based on the activity painting technique.Physics in medicine and biology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
30 authors.
Funding
Abstract
purposeCurrent brain-dedicated positron emission tomography (PET) systems (e.g., the High-Resolution Research Tomograph, HRRT) are unable to accurately and precisely measure pharmacologically-specific signals in small brain regions due to insufficient image resolution and sensitivity. The NeuroEXPLORER (NX), a new ultra-high-performance brain-dedicated scanner, promises to address these needs.
methodsSeven healthy individuals underwent paired scans on the HRRT and NX with targeted radiopharmaceuticals (
resultsThe exceptional spatial resolution of the NX can be appreciated in the details of the cortical ribbon and subcortical nuclei (e.g., mediodorsal thalamus) for
conclusionWe compared measurements of tracer uptake between an ultra-high-performance brain-dedicated PET system (NX) and the previous state-of-the-art system (HRRT) in the same subjects for seven different tracers, demonstrating a substantial gain in image detail, especially for small brain structures. We also discussed the implications of this technology for basic and clinical brain PET research and potential healthcare applications. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.